French pharmaceutical company Sanofi, one of the world’s largest drugmakers, will localize the production of medical products in Kazakhstan.
The agreement was reached following negotiations in Paris between Kazakh health Ministry officials and Sanofi representatives. Sanofi ranked tenth globally by revenue in 2024, earning $44.46 billion, according to Fierce Pharma.
“During the discussions, issues related to current joint projects with Kazakhstan in the field of pharmaceuticals, the supply and production of medicines, as well as the development and implementation of innovative medical technologies were touched upon,” the ministry said in a statement.
Talks also addressed broader cooperation with the French Development Agency (AFD) and Expertise France, which have been active in Kazakhstan’s healthcare sector. AFD, which opened a representative office in Astana in April, has already provided a €945,000 grant to improve medical infrastructure planning and management. Together with its subsidiary Proparco, the agency also financed a €90 million loan for the construction of a 630-bed hospital in Kokshetau.
Beyond healthcare, as previously reported by The Times of Central Asia, the AFD is supporting environmental initiatives in Kazakhstan, including a joint project with France to preserve Lake Balkhash.
